Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Standard of Care × Myeloid × Clear all

Status

Sponsor Class

Study Type

Interventional 5 Observational 1

Sponsor

Cancer Type

Breast 6 Genitourinary 5 Gastrointestinal 5 Plasma cell 4 Other hematologic neoplasm 2 Lymphoid 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Myeloid 1 Gynecologic 1 Dermatologic 1 CNS 1

Conditions

Thrombosis 1 Myeloproliferative Disorders 1

Interventions

Blood Specimen Collection 15 Imatinib Mesylate 8 Flow Cytometry 8 Surveys and Questionnaires 7 Polymerase Chain Reaction 7 ruxolitinib 5 ponatinib 5 nilotinib 5 Dasatinib 5 Therapeutics 4 Psychiatric Rehabilitation 4 Interviews as Topic 4 Cytogenetic Analysis 4 bosutinib 3 Biopsy 3 olverembatinib 2 Watchful Waiting 2 Observation 2 Microarray Analysis 2 Immunologic Techniques 2 Immunoenzyme Techniques 2 Hydroxyurea 2 High-Energy Shock Waves 2 Gene Expression Profiling 2 Data Collection 2 Bone Marrow Transplantation 2 Azacitidine 2 Amplified Fragment Length Polymorphism Analysis 2 venetoclax 1 quizartinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04631458 2021-09-16

Mascot

Royal Free Hospital NHS Foundation Trust

Myeloproliferative Disorders, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡